• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食组成与非酒精性脂肪性肝病管理中的体重减轻无关。

Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.

机构信息

Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2X8, Canada.

Cirrhosis Care Clinic and CEGIIR, University of Alberta, Edmonton, AB T6G 2X8, Canada.

出版信息

Nutrients. 2017 Jul 26;9(8):800. doi: 10.3390/nu9080800.

DOI:10.3390/nu9080800
PMID:28933748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5579594/
Abstract

Poor dietary composition is an important factor in the progression of non-alcoholic fatty liver disease (NAFLD). The majority of NAFLD patients follow diets with overconsumption of simple carbohydrates, total and saturated fat, with reduced intake of dietary fiber and omega-3 rich foods. Although lifestyle modifications including weight loss and exercise remain the keystone of NAFLD management, modifying dietary composition with or without a calorie-restricted diet may also be a feasible and sustainable strategy for NAFLD treatment. In the present review article, we highlight the potential therapeutic role of a "high quality healthy diet" to improve hepatic steatosis and metabolic dysfunction in patients with NAFLD, independent of caloric restriction and weight loss. We provide a literature review evaluating the evidence behind dietary components including fiber-, meat- and omega-3-rich diets and, pending further evidence, we concur with the EASL-EASD-EASO Clinical Guidelines recommendation of the Mediterranean diet as the diet of choice in these patients.

摘要

不良的饮食结构是非酒精性脂肪性肝病(NAFLD)进展的一个重要因素。大多数 NAFLD 患者的饮食中存在简单碳水化合物、总脂肪和饱和脂肪摄入过多,膳食纤维和富含 ω-3 的食物摄入减少的问题。尽管包括减肥和运动在内的生活方式改变仍然是 NAFLD 管理的基石,但在限制热量摄入的饮食基础上调整饮食结构也可能是治疗 NAFLD 的一种可行且可持续的策略。在本综述文章中,我们强调了“高质量健康饮食”在改善 NAFLD 患者肝脂肪变性和代谢功能障碍方面的潜在治疗作用,这种作用不依赖于热量限制和体重减轻。我们对饮食成分的相关文献进行了评估,包括富含纤维、肉类和 ω-3 的饮食,在有更多证据之前,我们同意 EASL-EASD-EASO 临床指南推荐地中海饮食作为这些患者的首选饮食。

相似文献

1
Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.饮食组成与非酒精性脂肪性肝病管理中的体重减轻无关。
Nutrients. 2017 Jul 26;9(8):800. doi: 10.3390/nu9080800.
2
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.热量均衡饮食变化与高心血管代谢风险个体的非酒精性脂肪肝
Nutrients. 2017 Sep 26;9(10):1065. doi: 10.3390/nu9101065.
3
The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms.地中海饮食模式作为非酒精性脂肪肝的首选饮食:证据和可能的机制。
Liver Int. 2017 Jul;37(7):936-949. doi: 10.1111/liv.13435. Epub 2017 Jun 1.
4
Health benefits of Mediterranean diet in nonalcoholic fatty liver disease.地中海饮食对非酒精性脂肪性肝病的健康益处。
Expert Rev Gastroenterol Hepatol. 2018 Sep;12(9):873-881. doi: 10.1080/17474124.2018.1503947. Epub 2018 Aug 1.
5
Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.基线 HOMA-IR 和循环 FGF21 水平可预测接受低碳水化合物饮食干预减肥的非酒精性脂肪性肝病患者的改善:一项前瞻性观察性初步研究。
Nutrients. 2020 Jul 18;12(7):2141. doi: 10.3390/nu12072141.
6
Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.非酒精性脂肪性肝病的饮食疗法:地中海饮食
World J Gastroenterol. 2014 Dec 7;20(45):16831-40. doi: 10.3748/wjg.v20.i45.16831.
7
Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD.超越体重减轻:NAFLD 中靶向肝内脂肪的饮食策略。
Nutrients. 2020 May 6;12(5):1316. doi: 10.3390/nu12051316.
8
Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.非酒精性脂肪肝和非酒精性脂肪性肝炎的生活方式改变。
Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835.
9
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.两种个性化饮食策略对肥胖和非酒精性脂肪性肝病患者代谢和肝脏的影响:肥胖相关性脂肪肝(FLiO)随机对照试验。
Nutrients. 2019 Oct 22;11(10):2543. doi: 10.3390/nu11102543.
10
Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner?地中海饮食与非酒精性脂肪性肝病:新的治疗选择即将出现?
World J Gastroenterol. 2014 Jun 21;20(23):7339-46. doi: 10.3748/wjg.v20.i23.7339.

引用本文的文献

1
100% Fish oil-based lipid emulsion inhibits hepatic stellate cell activation via suppression of the TGF-β1 autocrine signaling.100%基于鱼油的脂质乳剂通过抑制转化生长因子-β1自分泌信号传导来抑制肝星状细胞活化。
Hum Cell. 2025 Aug 27;38(5):153. doi: 10.1007/s13577-025-01283-y.
2
Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease.运动干预对代谢功能障碍相关脂肪性肝病患者的影响。
J Obes Metab Syndr. 2025 Jul 30;34(3):239-252. doi: 10.7570/jomes25028. Epub 2025 Jul 11.
3
Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial.间歇性禁食对代谢功能障碍相关脂肪性肝病患者肝脏脂肪变性和纤维化、血清成纤维细胞生长因子21及自噬标志物的影响:一项随机对照试验
Life (Basel). 2025 Apr 25;15(5):696. doi: 10.3390/life15050696.
4
Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes.代谢功能障碍相关脂肪性肝病与ω-6多不饱和脂肪酸:是友还是敌?
World J Hepatol. 2025 Mar 27;17(3):102286. doi: 10.4254/wjh.v17.i3.102286.
5
YouTube as a Source of Information for Dietary Guidance and Advisory Content in the Management of Non-Alcoholic Fatty Liver Disease.YouTube作为非酒精性脂肪性肝病管理中饮食指导和咨询内容的信息来源
Healthcare (Basel). 2025 Feb 7;13(4):351. doi: 10.3390/healthcare13040351.
6
Gut microbiota involvement in the effect of water-soluble dietary fiber on fatty liver and fibrosis.肠道微生物群参与水溶性膳食纤维对脂肪肝和肝纤维化的影响。
Biosci Microbiota Food Health. 2025;44(1):49-57. doi: 10.12938/bmfh.2024-046. Epub 2024 Aug 21.
7
The association between vitamin E intake and hepatic steatosis in general and obese populations.一般人群和肥胖人群中维生素E摄入量与肝脂肪变性之间的关联。
Nutr Metab (Lond). 2024 Jul 30;21(1):57. doi: 10.1186/s12986-024-00830-y.
8
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease.非酒精性脂肪性肝病生活方式干预依从性预测系统的验证。
World J Gastroenterol. 2024 May 28;30(20):2629-2632. doi: 10.3748/wjg.v30.i20.2629.
9
Association between processed and unprocessed red meat consumption and risk of nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis.加工和未加工的红肉摄入与非酒精性脂肪性肝病风险的关系:系统评价和剂量反应荟萃分析。
J Glob Health. 2024 Apr 26;14:04060. doi: 10.7189/jogh.14.04060.
10
Emerging Perspectives on the Set of Conditions That Lead to the Emergence of Metabolic Syndrome.关于导致代谢综合征出现的一系列病症的新观点
J Pers Med. 2023 Dec 26;14(1):32. doi: 10.3390/jpm14010032.

本文引用的文献

1
Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies.非酒精性脂肪性肝病的展望:当前及未来治疗方法概述
J Clin Transl Hepatol. 2017 Mar 28;5(1):67-75. doi: 10.14218/JCTH.2016.00061. Epub 2017 Mar 20.
2
The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms.地中海饮食模式作为非酒精性脂肪肝的首选饮食:证据和可能的机制。
Liver Int. 2017 Jul;37(7):936-949. doi: 10.1111/liv.13435. Epub 2017 Jun 1.
3
Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.生活方式干预对非酒精性脂肪性肝病患者临床特征的影响:一项荟萃分析。
Metabolism. 2017 Mar;68:119-132. doi: 10.1016/j.metabol.2016.12.006. Epub 2016 Dec 16.
4
Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids.非酒精性脂肪性肝病及其 n-3 多不饱和脂肪酸治疗。
Clin Nutr. 2018 Feb;37(1):37-55. doi: 10.1016/j.clnu.2017.01.006. Epub 2017 Jan 19.
5
Non-pharmacological interventions in non-alcoholic fatty liver disease patients.非酒精性脂肪性肝病患者的非药物干预措施。
Liver Int. 2017 Jan;37 Suppl 1:90-96. doi: 10.1111/liv.13311.
6
Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus.日本非酒精性脂肪性肝病和2型糖尿病患者的饮食摄入量比较。
J Clin Biochem Nutr. 2016 Nov;59(3):215-219. doi: 10.3164/jcbn.16-7. Epub 2016 Aug 19.
7
Association between rice, bread, and noodle intake and the prevalence of non-alcoholic fatty liver disease in Japanese middle-aged men and women.米饭、面包和面条的摄入与日本中年男女非酒精性脂肪肝患病率的关系。
Clin Nutr. 2017 Dec;36(6):1601-1608. doi: 10.1016/j.clnu.2016.09.034. Epub 2016 Oct 8.
8
Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by ¹H-MRS and Dual-Echo MRI.通过¹H-MRS和双回波MRI定量分析非酒精性脂肪性肝病患者饮食营养摄入与肝脏脂质含量之间的关联。
Nutrients. 2016 Aug 27;8(9):527. doi: 10.3390/nu8090527.
9
Metabolic aspects of adult patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病成年患者的代谢方面
World J Gastroenterol. 2016 Aug 21;22(31):7006-16. doi: 10.3748/wjg.v22.i31.7006.
10
Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease.坚持终止高血压膳食疗法(DASH)与非酒精性脂肪性肝病风险
Int J Food Sci Nutr. 2016 Dec;67(8):1024-9. doi: 10.1080/09637486.2016.1210101. Epub 2016 Jul 19.